Skip to content
OpenCapital
Get started

Bausch Health Companies BHC Bausch + Lomb — SG&A

Other segment segments

Salix
$105M-5.4%
International
$63M+21.2%
Diversified
$43M-4.4%
Solta Medical
$35M+25.0%

Similar metrics at other companies

Viavi Solutions Inc. logo
VIAVOptical Security and Performance Products — SG&A
$6.1M-4.7%
Arrowhead Research logo
ARWROperating Segment — SG&A
$41.74M+47.0%
Ashland logo
ASHLife Sciences — Selling General And Administrative Expense
$20M+5.3%
Ecolab logo
ECLGlobal Healthcare And Life Sciences — Selling General And Administrative Expense
$55.4M+4.5%
Agilent Technologies logo
ALife Sciences and Diagnostics Markets — Selling, General and Administrative Expense
$170M+8.3%
GHC
GHCSG&A
$277.48M+2.5%

Other financials

Income statement

See full
Revenue$2.5B+11.7%
Operating income-$950.0M-444%
Net income-$1.4B-2,353%
EPS (diluted)-$3.82-2,287%

Balance sheet

See full
Cash & equivalents$1.3B+13.4%
Total debt$20.8B-3.5%
Total equity-$2.1B-74.0%
Total assets$24.5B-7.3%

Cash flow

See full
Operating cash flow$230.0M+9.0%
CapEx$109.0M-5.2%
Free cash flow$121.0M+26.0%

Valuation

See full
Market cap$1.79B-15.9%
Enterprise value$21.24B-5.6%
P/S0.2×0.0×

Profitability

See full
Gross margin71.4%—
Operating margin5.6%-10.3pp
Net margin-1.9%-0.9pp
FCF margin9.8%-2.8pp

Returns & leverage

See full
Return on equity-70.1%—
Debt / equity45.2×—
Current ratio1.3×0.0×

Where this comes from

Reported directly by Bausch Health Companies in its filing.

Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.

The official record: Bausch Health Companies’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bausch Health Companies's bausch + lomb — sg&a.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bausch Health Companies's bausch + lomb — SG&A?
Bausch Health Companies (BHC) reported bausch + lomb — SG&A of $439M in Q1 2026.
How has Bausch Health Companies's bausch + lomb — SG&A changed year-over-year?
Bausch Health Companies's bausch + lomb — SG&A decreased by 1.8% year-over-year, from $447M to $439M.
What is the long-term trend for Bausch Health Companies's bausch + lomb — SG&A?
Over 3 years (2022 to 2025), Bausch Health Companies's bausch + lomb — SG&A has grown at a 12.5% compound annual growth rate (CAGR), from $1.25B to $1.78B.
What does bausch + lomb — SG&A mean?
Includes all non-production costs associated with operating the Bausch + Lomb segment, such as marketing, sales force expenses, and corporate overhead. Monitoring this metric helps assess the operational efficiency and cost-to-serve ratio of the segment's business model.